The Inside Analyst

The Inside Analyst

Inside the Portfolio #4 What Prevents Your Portfolio From Outperforming the S&P 500?

The Financial X-Ray analyses your holdings together, highlighting concentration, industry and geopolitical risks that aren’t obvious when looking at individual companies.

The Inside Analyst's avatar
The Inside Analyst
Jul 30, 2026
∙ Paid

If you’ve been reading Inside the Portfolio or my Monday evening stock analysis articles, you’ve probably noticed one recurring theme.

I rarely analyse financial metrics in isolation.

Strong margins don’t matter much if cash flow is deteriorating. High growth is less impressive if debt keeps rising. A cheap valuation isn’t attractive if the business is weakening etc.

Professional investors assess businesses as a whole and the same principle applies to portfolios.

Owning exceptional businesses doesn’t automatically create an exceptional portfolio.

So how can you be confident that you own high quality stocks and that these quality stocks form a strong portfolio?

That’s exactly what I built the Financial X-Ray Analysis Tool for.

A paid subscriber recently gave me permission to share the analysis that the Financial X-Ray performed on his portfolio.

The purpose is to share common pitfalls that most investors are not aware of. These pitfalls prevent the portfolio from beating the S&P 500.

Financial X-Ray portfolio overview showing an overall Balanced rating of 6.7/10, category ratings for valuation, financial health, management and outlook, together with eight portfolio holdings including Visa, Ferrari, Palo Alto Networks and CoreWeave.
Financial X-Ray portfolio overview showing an overall Balanced rating of 6.7/10, category ratings for valuation, financial health, management and outlook, together with eight portfolio holdings including Visa, Ferrari, Palo Alto Networks and CoreWeave.
At first glance, this portfolio looks balanced. The Financial X-Ray's initial assessment is positive—but the detailed analysis reveals several hidden risks that aren't obvious when looking at the holdings individually.

At first glance, this is a good portfolio.

It owns high-quality businesses across several industries. Financial health is strong, growth catalysts are present and many stocks are fairly priced. The overall rating of 6.7/10 reflects that.

But one thing stood out immediately.

Several holdings share the same underlying risks.

That’s not obvious when you analyse each company individually – but it becomes clear when you analyse the portfolio as one investment.

The Financial X-Ray is designed to uncover your:

  • Portfolio character

  • Structural strengths

  • Hidden risks

  • Holdings to watch

Behind the paywall I’ll reveal a verdict explaining what I’d be comfortable owning – and what I’d question and what prevents the portfolio from outperforming.

For most investors, this isn’t about finding another stock to buy.

It’s about gaining confidence in the portfolio they already own.

Or discovering a risk they hadn’t considered.

Explore the X-Ray

User's avatar

Continue reading this post for free, courtesy of The Inside Analyst.

Or purchase a paid subscription.
© 2026 The Inside Analyst · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture